NCT02117245

Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers

Phase I Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 14 (actual)
• Sponsor: Mirati Therapeutics Inc. · Industry
• Sex: All
• Age: 40 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to assess the bioavailability of the MGCD265 formulation following oral administration under fed conditions (Treatment-1) as compared to fasting conditions (Treatment-2) in healthy male and female volunteers.

Detailed description

The study objective is to assess the bioavailability of the MGCD265 formulation following oral administration under fed conditions (Treatment-1) as compared to fasting conditions (Treatment-2) in healthy male and female volunteers.

Conditions

• Healthy

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-10-01
• Completion: 2012-11-01
• First posted: 2014-04-17
• Last updated: 2015-01-08

Locations

1 site across 1 country: Canada